Follow
Stefano Volpi
Stefano Volpi
Istituto Giannina Gaslini, Università degli Studi di Genova, Harvard Medical School
Verified email at gaslini.org
Title
Cited by
Cited by
Year
On the alert for cytokine storm: immunopathology in COVID‐19
LA Henderson, SW Canna, GS Schulert, S Volpi, PY Lee, KF Kernan, ...
Arthritis & rheumatology 72 (7), 1059-1063, 2020
7392020
A three-dimensional model of human lung development and disease from pluripotent stem cells
YW Chen, SX Huang, ALRT De Carvalho, SH Ho, MN Islam, S Volpi, ...
Nature cell biology 19 (5), 542-549, 2017
5202017
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation
X Zhang, D Bogunovic, B Payelle-Brogard, V Francois-Newton, SD Speer, ...
Nature 517 (7532), 89-93, 2015
5102015
Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
MJ Ciancanelli, SXL Huang, P Luthra, H Garner, Y Itan, S Volpi, ...
Science 348 (6233), 448-453, 2015
4502015
Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients
E Traggiai, S Volpi, F Schena, M Gattorno, F Ferlito, L Moretta, A Martini
Stem cells 26 (2), 562-569, 2008
3552008
Type I interferon-mediated autoinflammation due to DNase II deficiency
MP Rodero, A Tesser, E Bartok, GI Rice, E Della Mina, M Depp, B Beitz, ...
Nature communications 8 (1), 2176, 2017
2002017
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
I Melki, Y Rose, C Uggenti, L Van Eyck, ML Frémond, N Kitabayashi, ...
Journal of Allergy and Clinical Immunology 140 (2), 543-552. e5, 2017
1792017
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
E Pontali, S Volpi, G Antonucci, M Castellaneta, D Buzzi, F Tricerri, ...
Journal of Allergy and Clinical Immunology 146 (1), 213-215, 2020
1482020
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
E Kyriazopoulou, T Huet, G Cavalli, A Gori, M Kyprianou, P Pickkers, ...
The Lancet Rheumatology 3 (10), e690-e697, 2021
1402021
Type I interferonopathies in pediatric rheumatology
S Volpi, P Picco, R Caorsi, F Candotti, M Gattorno
Pediatric Rheumatology 14, 1-12, 2016
1302016
B cell–intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice
M Recher, SO Burns, MA de la Fuente, S Volpi, C Dahlberg, JE Walter, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2819-2828, 2012
1242012
Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients
ML Frémond, A Hadchouel, L Berteloot, I Melki, V Bresson, L Barnabei, ...
The Journal of Allergy and Clinical Immunology: In Practice 9 (2), 803-818. e11, 2021
1132021
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency
I Brigida, M Zoccolillo, MP Cicalese, L Pfajfer, F Barzaghi, S Scala, ...
Blood, The Journal of the American Society of Hematology 132 (22), 2362-2374, 2018
1082018
Type I interferon pathway activation in COPA syndrome
S Volpi, J Tsui, M Mariani, C Pastorino, R Caorsi, O Sacco, A Ravelli, ...
Clinical Immunology 187, 33-36, 2018
1042018
Inborn errors of RNA lariat metabolism in humans with brainstem viral infection
SY Zhang, NE Clark, CA Freije, E Pauwels, AJ Taggart, S Okada, ...
Cell 172 (5), 952-965. e18, 2018
1032018
Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis
M Bruschi, A Bonanni, A Petretto, A Vaglio, F Pratesi, L Santucci, ...
The Journal of rheumatology 47 (3), 377-386, 2020
992020
Powering the immune system: mitochondria in immune function and deficiency
MA Walker, S Volpi, KB Sims, JE Walter, E Traggiai
Journal of immunology research 2014, 2014
922014
Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity
F Schena, S Volpi, CE Faliti, F Penco, S Santi, M Proietti, U Schenk, ...
Cell reports 3 (6), 1824-1831, 2013
922013
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency
S Volpi, MP Cicalese, P Tuijnenburg, ATJ Tool, E Cuadrado, ...
Journal of Allergy and Clinical Immunology 143 (6), 2296-2299, 2019
892019
Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome
S Volpi, A Insalaco, R Caorsi, E Santori, V Messia, O Sacco, ...
Journal of clinical immunology 39, 476-485, 2019
882019
The system can't perform the operation now. Try again later.
Articles 1–20